GRAIL and Multi-Cancer Early Detection: An Update from ESMO | Megan Hall, PhD
Learn about how multi-cancer early detection screening works and about important new data from GRAIL's PATHFINDER study as presented at ESMO.
▶︎
Genetic Testing Pathways for Cancer of Unknown Primary (North Thames, East and South West Regions)
▶︎
25: Research Update on Multi-Cancer Early Detection with Dr. Eric Klein
▶︎
Approved and Investigation Therapies for TGCT by Dr Vicki Keedy
▶︎
Peter Attia, MD: How to Detect Cancer Early - Before it Spreads
▶︎
ctDNA and MRD | 2023 Best of GI Cancer Conference
▶︎
Effectiveness of a Virtual Tobacco Treatment for Cancer Patients
▶︎
Grail expected to be first FDA-approved multi-cancer test, says CEO Bob Ragusa
▶︎
Liquid Biopsy, AI, and Other Global Innovations From 2026 ASCO Breakthrough
▶︎
Is the race to cure cancer fixed? | Decoded
▶︎
Undiagnosed Diseases Network Grand Rounds - Vanderbilt Clinical Site - July 2026
▶︎
Cancer 101: Cancer Prevention
▶︎
Precision Over Presumption with Abigail Mathews | U of T TRP Capstone Defense 2026
▶︎
How I Learned I had Pancreatic Cancer: My First Signs - Roger | The Patient Story
▶︎
NEW CANCER DISCOVERY - Simple Blood Test to Detect Cancer (ctDNA)
▶︎
267 ‒ The latest in cancer therapeutics, diagnostics, and early detection | Keith Flaherty, M.D.
▶︎
Can a Simple Blood Draw Catch Cancer Early? Inside GRAIL's Groundbreaking Work
▶︎
APIC Great Lakes July 2026: Infection Prevention in Ambulatory Care
▶︎
Metastatic Breast Cancer: What You Need to Know
▶︎
DEVICE Trial
▶︎